Chemists forge a new path in the search for antibiotics

June 1, 2017
Scientists at Yale University are working on a chemical process that may lead to the creation of a new class of antibiotics. Credit: Michael S. Helfenbein

Yale University scientists have developed a novel chemical process that may lead to the creation of a new class of antibiotics.

The discovery comes at a time when more types of bacteria are becoming resistant to existing antibiotics, increasing the occurrence of lethal infections. The ability to create would have significant ramifications for medical treatment and public health, said the researchers.

"This is one way to focus our talents as synthetic chemists in a direction that can immediately help patients," said Seth Herzon, a chemistry professor at Yale and member of the Yale Cancer Center. Herzon is principal investigator of a new study published June 1 in the journal Science.

Yale postdoctoral fellow Stephen Murphy and Yale graduate student Mingshuo Zeng are co-authors of the study. Both are members of the Herzon Lab.

The new process makes it possible to create molecules related to the natural product pleuromutilin from simple commercial chemicals in the laboratory. Pleuromutilin is produced by a fungus and was found to have useful in the early 1950s. Since then, scientists in academia and the have created thousands of pleuromutilin derivatives by a process known as semisynthesis, which involves chemically modifying pleuromutilin itself. However, a large proportion of these derivatives only vary at a single position in the molecule. A practical full , which would make a wealth of additional antibiotics possible, has remained elusive.

Herzon first attempted to find a solution in 2008. "We worked on this project for a few years when I started at Yale, but didn't record much success," Herzon said. "The pharmaceutical industry has historically been the driving force behind antibiotics development. However, are essentially at the bottom of the list in terms of investment return. Consequently, most major pharmaceuticals have walked away from this area."

This has led to a dearth of new drugs to combat resistance, Herzon added. "As the anti-bacterial crisis kept getting worse, we decided we had to pick this back up and conceive an entirely different approach," he said.

Herzon and his colleagues discovered they could prepare an isomer of pleuromutilin—a compound that has the same connectivity, but with a different arrangement of atoms—and rearrange it in the final steps of the synthesis to pleuromutilin. The discovery allowed the group to vault past some of the previous roadblocks and achieve the full synthesis of pleuromutilin. Moreover, these isomers have better antibacterial properties than pleuromutilin itself, opening the door to the preparation of improved .

"Making pleuromutilin is great, but we are more interested in the non-natural compounds we can access through synthesis. We're continuing to refine the synthesis, and the sky is the limit now, in terms of the modifications we can make," Herzon explained. "We're going to start testing compounds immediately. If all goes well we ultimately hope to move our compounds into clinical trials to treat drug-resistant infections."

Explore further: A 'home run' approach: Team finds new ways to synthesize HIV inhibitor

More information: "A modular and enantioselective synthesis of the pleuromutilin antibiotics" Science (2017). science.sciencemag.org/cgi/doi … 1126/science.aan0003

Related Stories

A faster and cheaper way to produce new antibiotics

May 4, 2016

A novel way of synthesising a promising new antibiotic has been identified by scientists at the University of Bristol. By expressing the genes involved in the production of pleuromutilin in a different type of fungus, the ...

Team screens cardiac drugs that also attack cancer

March 14, 2016

Several drugs now being used to treat heart failure and atrial arrhythmia also show promise as DNA disruptors in cancer cells and could be readily repurposed as anticancer agents, according to a new study by Yale researchers.

Scientists Synthesize Unique Family of Anti-Cancer Compounds

February 12, 2010

(PhysOrg.com) -- Yale University scientists have streamlined the process for synthesizing a family of compounds with the potential to kill cancer and other diseased cells, and have found that they represent a unique category ...

Recommended for you

New X-ray spectroscopy explores hydrogen-generating catalyst

November 22, 2017

Using a newly developed technique, researchers from Japan, Germany and the U.S. have identified a key step in production of hydrogen gas by a bacterial enzyme. Understanding these reactions could be important in developing ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.